|
Volumn 169, Issue 5, 1998, Pages 280-284
|
Dysfunctional uterine bleeding
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIFIBRINOLYTIC AGENT;
DANAZOL;
GESTAGEN;
GONADORELIN AGONIST;
LEVONORGESTREL;
MEFENAMIC ACID;
NONSTEROID ANTIINFLAMMATORY AGENT;
NORETHISTERONE;
ORAL CONTRACEPTIVE AGENT;
PROSTACYCLIN;
PROSTAGLANDIN;
PROSTANOID;
THROMBOXANE;
ARTICLE;
BALLOON;
CLINICAL TRIAL;
ENDOMETRIUM ABLATION;
FEMALE;
HUMAN;
HYSTERECTOMY;
METRORRHAGIA;
ORAL DRUG ADMINISTRATION;
PATIENT SATISFACTION;
SIDE EFFECT;
TREATMENT OUTCOME;
UTERUS BLEEDING;
ADOLESCENT;
ADULT;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTIFIBRINOLYTIC AGENTS;
CONTRACEPTIVES, ORAL;
DANAZOL;
ENDOMETRIUM;
ESTROGEN ANTAGONISTS;
FEMALE;
GONADOTROPIN-RELEASING HORMONE;
HUMANS;
HYSTERECTOMY;
MENORRHAGIA;
MIDDLE AGED;
OVULATION;
PATIENT SATISFACTION;
PROGESTINS;
TREATMENT OUTCOME;
|
EID: 0031798454
PISSN: 00930415
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (35)
|
References (13)
|